Search research articles
Contact Us
Filters
Showing results (141-150 of 178) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle
M André, M Henry-Amar, J L Pico, et al.
Leukemia
|
October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire
M Mohty, M Labopin, M L Balère, et al.
British Journal of Haematology
|
February 14, 2002
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemia
A Pigneux, M L Tanguy, M Michallet, et al.
British Journal of Haematology
|
June 1, 1997
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade
P A Rowlings, D Przepiorka, J P Klein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†
S P Robinson, A Boumendil, H Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome
M Michallet, K Bilger, F Garban, et al.
Leukemia
|
May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
M Mohty, K Bilger, E Jourdan, et al.
Bone Marrow Transplantation
|
June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S P Robinson, C Canals, J J Luang, et al.
Blood
|
November 5, 1997
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)
J L Harousseau, J Y Cahn, B Pignon, et al.
Bone Marrow Transplantation
|
May 16, 2003
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society
H Espérou, J-M Boiron, J-M Cayuela, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 178) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle
M André, M Henry-Amar, J L Pico, et al.
Leukemia
|
October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire
M Mohty, M Labopin, M L Balère, et al.
British Journal of Haematology
|
February 14, 2002
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemia
A Pigneux, M L Tanguy, M Michallet, et al.
British Journal of Haematology
|
June 1, 1997
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade
P A Rowlings, D Przepiorka, J P Klein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†
S P Robinson, A Boumendil, H Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome
M Michallet, K Bilger, F Garban, et al.
Leukemia
|
May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
M Mohty, K Bilger, E Jourdan, et al.
Bone Marrow Transplantation
|
June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S P Robinson, C Canals, J J Luang, et al.
Blood
|
November 5, 1997
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)
J L Harousseau, J Y Cahn, B Pignon, et al.
Bone Marrow Transplantation
|
May 16, 2003
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society
H Espérou, J-M Boiron, J-M Cayuela, et al.
Page
of 18